ARTICLE | Company News
Oncogene other research news
May 28, 1996 7:00 AM UTC
ONCS received a $631,000 Phase II SBIR from the National Institutes of Allergy and Infectious Diseases to screen 100,000 samples, including 50,000 fungal extracts and an equal number of compounds from...